| 1 | [SID24804137] | Active | AbsAC35_uM | 0.185 | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity [AID652041, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | AbsAC35_uM | 0.185 [uM] | | BioAssay | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity | | AID | 652041 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID24804137] | Active | AbsAC35_uM | 0.484 | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity [AID652047, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | AbsAC35_uM | 0.484 [uM] | | BioAssay | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity | | AID | 652047 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID24804137] | Active | EC50 | 0.56 | Fluorescence Cell-Based Retest of C. albicans Growth in the Presence of Fluconazole [AID2467, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | EC50 | 0.56 [uM] | | BioAssay | Fluorescence Cell-Based Retest of C. albicans Growth in the Presence of Fluconazole | | AID | 2467 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID24804137] | Active | EC50 | 0.788 | Fluorescence Cell-Based Secondary Assay to Identify Inhibitors of Resistant C. albicans Growth in the Presence of Fluconazole [AID2423, Type: confirmatory] | heat shock protein 90 [Candida albicans] [gi:994798] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | EC50 | 0.788 [uM] | | BioAssay | Fluorescence Cell-Based Secondary Assay to Identify Inhibitors of Resistant C. albicans Growth in the Presence of Fluconazole | | AID | 2423 | | BioAssay type | confirmatory | | Target | heat shock protein 90 [Candida albicans] [gi:994798] | | PubMed | | | Data Table |  |
|
| 5 | [SID103664738] | Active | IC50 | 1 | Inhibition of human platelet-type N-terminally His6-tagged 12-lipoxygenase assessed as conjugated diene product formation using arachidonic acid by UV-vis spectrophotometer analysis [AID611382, Type: Literature] | Arachidonate 12-lipoxygenase, 12S-type [gi:125987838] |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103664738 | | CID | 2920571 | | Outcome | Active | | IC50 | 1 [uM] | | BioAssay | Inhibition of human platelet-type N-terminally His6-tagged 12-lipoxygenase assessed as conjugated diene product formation using arachidonic acid by UV-vis spectrophotometer analysis | | AID | 611382 | | BioAssay type | Literature | | Target | Arachidonate 12-lipoxygenase, 12S-type [gi:125987838] | | PubMed | 21739938 | | Data Table |  |
|
| 6 | [SID103664738] | Active | IC50 | 1 | Inhibition of human platelet-type N-terminally His6-tagged 12-lipoxygenase assessed as conjugated diene product formation using arachidonic acid by UV-vis spectrophotometer analysis [AID611382, Type: Literature] | Arachidonate 12-lipoxygenase, 12S-type [gi:125987838] |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103664738 | | CID | 2920571 | | Outcome | Active | | IC50 | 1 [uM] | | BioAssay | Inhibition of human platelet-type N-terminally His6-tagged 12-lipoxygenase assessed as conjugated diene product formation using arachidonic acid by UV-vis spectrophotometer analysis | | AID | 611382 | | BioAssay type | Literature | | Target | Arachidonate 12-lipoxygenase, 12S-type [gi:125987838] | | PubMed | 21739938 | | Data Table |  |
|
| 7 | [SID85736356] | Active | Potency | 1 | Cuvette-Based Assay for Inhibitors of 12-hLO (12-human lipoxygenase): 8HQ Series - Round 1 [AID2163, Type: confirmatory] | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 85736356 | | CID | 2920571 | | Outcome | Active | | Potency | 1 [uM] | | BioAssay | Cuvette-Based Assay for Inhibitors of 12-hLO (12-human lipoxygenase): 8HQ Series - Round 1 | | AID | 2163 | | BioAssay type | confirmatory | | Target | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] | | PubMed | | | Data Table |  |
|
| 8 | [SID85736356] | Active | Potency | 1 | Cuvette-Based Assay for Inhibitors of 12-hLO (12-human lipoxygenase): 8HQ Series - Round 1 [AID2163, Type: confirmatory] | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 85736356 | | CID | 2920571 | | Outcome | Active | | Potency | 1 [uM] | | BioAssay | Cuvette-Based Assay for Inhibitors of 12-hLO (12-human lipoxygenase): 8HQ Series - Round 1 | | AID | 2163 | | BioAssay type | confirmatory | | Target | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] | | PubMed | | | Data Table |  |
|
| 9 | [SID24804137] | Active | AC50 | 1.31 | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_Dose_CherryPick_Activity [AID624132, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | AC50 | 1.31 [uM] | | BioAssay | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_Dose_CherryPick_Activity | | AID | 624132 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID24804137] | Active | Potency | 1.4125 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | Potency | 1.4125 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 11 | [SID24804137] | Active | EC50 | 1.967 | Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of T.Cruzi Replication. [AID2044, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | EC50 | 1.967 [uM] | | BioAssay | Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of T.Cruzi Replication. | | AID | 2044 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID24804137] | Active | Potency | 2.5929 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | Potency | 2.5929 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 13 | [SID24804137] | Active | Potency | 2.8184 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 14 | [SID24804137] | Active | AbsAC1000_uM | 2.994 | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity [AID540271, Type: confirmatory] | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | AbsAC1000_uM | 2.994 [uM] | | BioAssay | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity | | AID | 540271 | | BioAssay type | confirmatory | | Target | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] | | PubMed | | | Data Table |  |
|
| 15 | [SID24804137] | Active | AC50 | 3.57 | Shn3: Dual-Go Shn3RL cells Measured in Cell-Based System Using Plate Reader - 2134-02_Inhibitor_Dose_CherryPick_Activity [AID624133, Type: confirmatory] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | AC50 | 3.57 [uM] | | BioAssay | Shn3: Dual-Go Shn3RL cells Measured in Cell-Based System Using Plate Reader - 2134-02_Inhibitor_Dose_CherryPick_Activity | | AID | 624133 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID24804137] | Active | Potency | 3.6626 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID24804137] | Active | Potency | 3.6626 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 18 | [SID24804137] | Active | Potency | 3.6626 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 19 | [SID24804137] | Active | Potency | 3.6626 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 20 | [SID85736356] | Active | Potency | 5.0119 | Confirmation qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) [AID2162, Type: confirmatory] | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 85736356 | | CID | 2920571 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | Confirmation qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) | | AID | 2162 | | BioAssay type | confirmatory | | Target | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] | | PubMed | | | Data Table |  |
|
| 21 | [SID85736356] | Active | Potency | 5.0119 | Confirmation qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) [AID2162, Type: confirmatory] | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 85736356 | | CID | 2920571 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | Confirmation qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase) | | AID | 2162 | | BioAssay type | confirmatory | | Target | arachidonate 12-lipoxygenase, 12S-type [Homo sapiens] [gi:154426292] | | PubMed | | | Data Table |  |
|
| 22 | [SID85736356] | Active | Potency | 6.3096 | Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E): 8HQs - Round 1 [AID493212, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 85736356 | | CID | 2920571 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E): 8HQs - Round 1 | | AID | 493212 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 23 | [SID85736356] | Active | Potency | 6.3096 | Confirmation qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2677, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 85736356 | | CID | 2920571 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | Confirmation qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2677 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 24 | [SID24804137] | Active | Potency | 6.3096 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID24804137] | Active | Potency | 7.0795 | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 26 | [SID24804137] | Active | Potency | 7.0795 | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 27 | [SID24804137] | Active | EC50 | 7.205 | Luminescence Cell-Based Dose Response HTS Screen to Identify Cytotoxic Compounds of NIH3T3 cells. [AID2010, Type: confirmatory] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | EC50 | 7.205 [uM] | | BioAssay | Luminescence Cell-Based Dose Response HTS Screen to Identify Cytotoxic Compounds of NIH3T3 cells. | | AID | 2010 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID24804137] | Active | AC50 | 7.81 | Shn3: Cytotox assay Measured in Cell-Based System Using Plate Reader - 2134-03_Inhibitor_Dose_CherryPick_Activity [AID624134, Type: confirmatory] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | AC50 | 7.81 [uM] | | BioAssay | Shn3: Cytotox assay Measured in Cell-Based System Using Plate Reader - 2134-03_Inhibitor_Dose_CherryPick_Activity | | AID | 624134 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID24804137] | Active | Potency | 9.2 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | Potency | 9.2 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 30 | [SID24804137] | Active | Potency | 9.2 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | Potency | 9.2 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 31 | [SID24804137] | Active | Potency | 9.2 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | Potency | 9.2 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 32 | [SID24804137] | Active | Potency | 9.2 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | Potency | 9.2 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 33 | [SID24804137] | Active | Potency | 11.2202 | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | Alpha-synuclein [gi:586067] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | Alpha-synuclein [gi:586067] | | PubMed | | | Data Table |  |
|
| 34 | [SID24804137] | Active | Potency | 11.2202 | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | Alpha-synuclein [gi:586067] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | Alpha-synuclein [gi:586067] | | PubMed | | | Data Table |  |
|
| 35 | [SID24804137] | Active | EC50 | 19.087 | Fluorescence Cell-Based Secondary Assay to Measure Toxicity of Compounds Not in the Presence of Fluconazole [AID2387, Type: confirmatory] | heat shock protein 90 [Candida albicans] [gi:994798] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | EC50 | 19.087 [uM] | | BioAssay | Fluorescence Cell-Based Secondary Assay to Measure Toxicity of Compounds Not in the Presence of Fluconazole | | AID | 2387 | | BioAssay type | confirmatory | | Target | heat shock protein 90 [Candida albicans] [gi:994798] | | PubMed | | | Data Table |  |
|
| 36 | [SID24804137] | Active | EC50 | 24.857 | Fluorescence Cell-Based Secondary Assay for toxicity in mammalian fibroblasts [AID2327, Type: confirmatory] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | EC50 | 24.857 [uM] | | BioAssay | Fluorescence Cell-Based Secondary Assay for toxicity in mammalian fibroblasts | | AID | 2327 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID24804137] | Active | Potency | 44.6684 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 38 | [SID24804137] | Active | AbsAC35_uM | 49.06 | Mammalian cell toxicity counterscreen to identify toxic HSP40 inhibitor compounds in NIH3T3 cells Measured in Cell-Based System Using Plate Reader - 2120-03_Inhibitor_Dose_CherryPick_Activity_Set2 [AID624265, Type: confirmatory] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | AbsAC35_uM | 49.06 [uM] | | BioAssay | Mammalian cell toxicity counterscreen to identify toxic HSP40 inhibitor compounds in NIH3T3 cells Measured in Cell-Based System Using Plate Reader - 2120-03_Inhibitor_Dose_CherryPick_Activity_Set2 | | AID | 624265 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID24804137] | Active | | | Fluorescence Cell-Based Primary HTS of C.albicans growth in the presence of Fluconazole and compound [AID1979, Type: screening] | heat shock protein 90 [Candida albicans] [gi:994798] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | BioAssay | Fluorescence Cell-Based Primary HTS of C.albicans growth in the presence of Fluconazole and compound | | AID | 1979 | | BioAssay type | screening | | Target | heat shock protein 90 [Candida albicans] [gi:994798] | | PubMed | | | Data Table |  |
|
| 40 | [SID85817670] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway [AID2313, Type: screening] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 85817670 | | CID | 2920571 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway | | AID | 2313 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID85858111] | Active | | | Inhibition of HepG2 cell line [AID2303, Type: screening] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 85858111 | | CID | 2920571 | | Outcome | Active | | BioAssay | Inhibition of HepG2 cell line | | AID | 2303 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID24804137] | Active | | | Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability [AID449728, Type: screening] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability | | AID | 449728 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID24804137] | Active | | | Phenotypic HTS multiplex for antifungal efflux pump inhibitors [AID485275, Type: screening] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | BioAssay | Phenotypic HTS multiplex for antifungal efflux pump inhibitors | | AID | 485275 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID24804137] | Active | | | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors [AID1813, Type: screening] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | BioAssay | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors | | AID | 1813 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID24804137] | Active | | | Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication [AID1885, Type: screening] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | BioAssay | Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication | | AID | 1885 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID24804137] | Active | | | qHTS Assay for Inhibitors of the CtBP/E1A Interaction [AID651724, Type: screening] | CtBP interacting protein CtIP [Homo sapiens] [gi:1730321] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of the CtBP/E1A Interaction | | AID | 651724 | | BioAssay type | screening | | Target | CtBP interacting protein CtIP [Homo sapiens] [gi:1730321] | | PubMed | | | Data Table |  |
|
| 47 | [SID24804137] | Active | | | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction [AID651725, Type: screening] | six1 [Homo sapiens] [gi:1246761] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction | | AID | 651725 | | BioAssay type | screening | | Target | six1 [Homo sapiens] [gi:1246761] | | PubMed | | | Data Table |  |
|
| 48 | [SID24804137] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the HTRA serine peptidase 1 (HTRA1) [AID540248, Type: other] | HTRA1 protein [gi:121945198] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the HTRA serine peptidase 1 (HTRA1) | | AID | 540248 | | BioAssay type | other | | Target | HTRA1 protein [gi:121945198] | | PubMed | | | Data Table |  |
|
| 49 | [SID24804137] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) [AID504803, Type: screening] | HTRA1 protein [gi:121945198] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24804137 | | CID | 2920571 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) | | AID | 504803 | | BioAssay type | screening | | Target | HTRA1 protein [gi:121945198] | | PubMed | | | Data Table |  |
|
| 50 | [SID85858111] | Active | | | Inhibition of P. falciparum Dd2 [AID2302, Type: screening] | lactate dehydrogenase [Plasmodium falciparum] [gi:111034851] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 85858111 | | CID | 2920571 | | Outcome | Active | | BioAssay | Inhibition of P. falciparum Dd2 | | AID | 2302 | | BioAssay type | screening | | Target | lactate dehydrogenase [Plasmodium falciparum] [gi:111034851] | | PubMed | | | Data Table |  |
|